Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapeutic inertia in obesity management among people living with obesity from the perspective of general/family practitioners in Canada: A mixed-methods study.

Clinical obesity·2024
Same author

Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial.

The lancet. Diabetes & endocrinology·2024
Same author

Acute and chronic complication profiles among patients with chronic kidney disease in Alberta, Canada: a retrospective observational study.

BMC nephrology·2024
Same author

Cost-effectiveness of weight-management pharmacotherapies in Canada: a societal perspective.

International journal of obesity (2005)·2024
Same author

Obesity management from the perspectives of people living with obesity in Canada: A mixed-methods study.

Diabetes, obesity & metabolism·2024
Same author

Prevalence of Adult Type 2 Diabetes Mellitus and Related Complications in Alberta, Canada: A Retrospective, Observational Study Using Administrative Data.

Canadian journal of diabetes·2023

Related Experiment Video

Updated: Jun 13, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Diabetes and weight management.

David C W Lau1

  • 1Julia McFarlane Diabetes Research Centre, University of Calgary, Alberta, Canada. dcwlau@ucalgary.ca

Primary Care Diabetes
|April 17, 2010
PubMed
Summary

Losing 5-10% of body weight significantly improves diabetes control. Insulin detemir offers an effective basal insulin option with less associated weight gain compared to other insulins, aiding diabetes management.

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Pharmacology

Background:

  • Diabetes mellitus is a major global non-communicable chronic disease, exacerbated by the obesity epidemic.
  • Weight management is crucial for effective diabetes control, with 5-10% weight loss improving glycemic, lipid, and blood pressure levels.
  • Basal insulin therapy is a key component in managing type 2 diabetes.

Purpose of the Study:

  • To evaluate the efficacy and weight profile of insulin detemir in type 2 diabetes management.
  • To compare insulin detemir with other basal insulin options (NPH, glargine) regarding weight changes.
  • To assess the role of insulin detemir in patients also utilizing lifestyle interventions and oral anti-diabetic agents.

Main Methods:

  • Comparative analysis of clinical trial data for insulin detemir, NPH, and insulin glargine.

More Related Videos

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

Related Experiment Videos

Last Updated: Jun 13, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

  • Assessment of glycemic control (blood sugar levels) and weight changes in patients with type 2 diabetes.
  • Review of studies involving patients on lifestyle interventions and oral anti-diabetic agents requiring basal insulin.
  • Main Results:

    • Insulin detemir demonstrated efficacy in improving glycemic control.
    • Insulin detemir was associated with less weight gain compared to insulin NPH and insulin glargine.
    • A modest weight loss of 5-10% led to significant improvements in metabolic parameters.

    Conclusions:

    • Insulin detemir is an effective basal insulin analogue for type 2 diabetes management.
    • Its favorable weight profile makes it a valuable option, particularly in the context of the obesity epidemic.
    • Once-daily insulin detemir can be considered for patients with type 2 diabetes on existing therapies who need insulin introduction.